Spectrum Asset Management (California)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Spectrum Asset Management (California)'s NVS Position: Q2 2026 in Review
Spectrum Asset Management (California) reduced its Novartis (NVS) stake by 13% in Q2 2026, selling an estimated $520K and leaving 22,804 shares worth $3.57M. The position accounts for 0.99% of the portfolio, ranked #32.
Spectrum Asset Management (California) first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.01M in Q1 2026. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Spectrum Asset Management (California) held 22,804 shares of Novartis worth $3.57M as of Q2 2026.
- Spectrum Asset Management (California) sold 3,471 Novartis shares in Q2 2026, an estimated $520K.
- Novartis made up 0.99% of Spectrum Asset Management (California)'s portfolio in Q2 2026, its #32 holding.
- Spectrum Asset Management (California) first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
- Spectrum Asset Management (California)'s Novartis position peaked at $4.01M in Q1 2026.
- 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Spectrum Asset Management (California)'s 13F filing for Q2 2026, filed 3 Aug 2026.